Data updated: Mar 10, 2026
TRIAMCINOLONE ACETONIDE
TRIAMCINOLONE ACETONIDE
Approved 1958-10-23
69
Indications
--
Phase 3 Trials
67
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1958-10-23
- Routes
- TOPICAL, INJECTION, NASAL, DENTAL
- Dosage Forms
- OINTMENT, CREAM, INJECTABLE, LOTION, SPRAY, METERED, PASTE, SPRAY
Companies
MORTON GROVE TOPIDERM CAPLIN PAI HOLDINGS PHARM AMNEAL Teva Hikma EXTROVIS FOUGERA PHARMS PADAGIS US COSETTE Novartis PARNELL GLENMARK PHARMS LTD PADAGIS ISRAEL QUAGEN SENORES PHARMS SUN PHARMA CANADA PERRIGO PHARMA INTL ALPHARMA US PHARMS PHARMADERM ENCUBE LONG GROVE PHARMS Apotex TARO PHARMOBEDIENT SCIEGEN PHARMS CHARTWELL RX STRIDES PHARMA Viatris EUGIA PHARMA ALEMBIC NORVIUM BIOSCIENCE BEACH PRODS Dr. Reddy's GLENMARK SPECLT MACLEODS PHARMS LTD Aurobindo Pharma MICRO LABS WATSON LABS EPIC PHARMA LLC PHARMAFAIR AMBIX ALKEM LABS LTD RISING
Active Ingredient: TRIAMCINOLONE ACETONIDE
Website: ↗
TRIAMCINOLONE ACETONIDE Approval History
Loading approval history...
What TRIAMCINOLONE ACETONIDE Treats
69 FDA approvalsOriginally approved for its first indication in 1958 . Covers 69 distinct patient populations.
- Other (69)
Other
(69 approvals)- • Approved indication (Oct 1958)
- • Approved indication (Jul 1963)
- • Approved indication (Mar 1978)
- • Approved indication (Apr 1979)
- • Approved indication (Apr 1981)
- • Approved indication (Nov 1981)
- • Approved indication (Jun 1982)
- • Approved indication (Jun 1982)
- • Approved indication (Sep 1982)
- • Approved indication (Dec 1982)
- • Approved indication (May 1983)
- • Approved indication (Apr 1985)
- • Approved indication (Apr 1985)
- • Approved indication (Aug 1986)
- • Approved indication (Oct 1986)
- • Approved indication (Oct 1987)
- • Approved indication (Dec 1988)
- • Approved indication (Feb 1989)
- • Approved indication (May 1991)
- • Approved indication (Sep 1994)
- • Approved indication (Oct 1994)
- • Approved indication (Nov 1997)
- • Approved indication (Jun 2001)Label Letter
- • Approved indication (Apr 2003)
- • Approved indication (Jun 2006)
- • Approved indication (Dec 2006)
- • Approved indication (May 2009)Letter
- • Approved indication (Jun 2009)Letter
- • Approved indication (Jul 2009)Label Letter
- • Approved indication (Jul 2010)
- • Approved indication (May 2013)
- • Approved indication (Apr 2015)
- • Approved indication (May 2016)
- • Approved indication (Jul 2016)
- • Approved indication (Jul 2016)
- • Approved indication (Aug 2016)
- • Approved indication (Aug 2016)
- • Approved indication (Dec 2016)
- • Approved indication (Jan 2017)
- • Approved indication (Feb 2017)
- • Approved indication (Mar 2017)
- • Approved indication (Aug 2017)
- • Approved indication (Sep 2017)
- • Approved indication (Sep 2017)
- • Approved indication (Oct 2017)
- • Approved indication (Dec 2017)Letter
- • Approved indication (Dec 2017)
- • Approved indication (May 2018)
- • Approved indication (Oct 2018)
- • Approved indication (Oct 2018)
- • Approved indication (Nov 2018)
- • Approved indication (Feb 2019)
- • Approved indication (Nov 2019)Letter
- • Approved indication (Mar 2020)
- • Approved indication (Jun 2020)Letter
- • Approved indication (Jul 2020)
- • Approved indication (Nov 2020)
- • Approved indication (Feb 2021)
- • Approved indication (Jan 2022)
- • Approved indication (Jul 2022)
- • Approved indication (Nov 2022)
- • Approved indication (Dec 2022)
- • Approved indication (Jan 2023)
- • Approved indication (Jan 2023)
- • Approved indication (Aug 2023)
- • Approved indication (Dec 2024)
- • Approved indication (Mar 2025) New
- • Approved indication (Apr 2025) New
- • Approved indication (Oct 2025) New
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
TRIAMCINOLONE ACETONIDE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.